LYVE1 and neoplasm: These data suggest that loss of LYVE-1+ macrophages in the tumor microenvironment leads to a positive shift toward a proinflammatory phenotype in the remaining macrophages, indicating that when LYVE-1+ macrophages are present, they promote an anti-inflammatory environment in tumors.